Resmed will release its second quarter fiscal 2026 financial and operational results on Thursday, January 29, 2026, after the New York Stock Exchange closes. Management will host a live webcast at 1:30 p.m. PST (4:30 p.m. EST), with international participation scheduled for 9:30 p.m. GMT in London and 8:30 a.m. AEDT in Sydney. Investors can access the call via Resmed’s investor relations site; no outside phone lines are used. A replay will be posted approximately two hours after the webcast on Resmed’s website, while a phone replay (U.S.: +1 877.660.6853; International: +1 201.612.7415; Conference ID: 13757750) will be available from January 29 until February 12.

Resmed’s recent commentary highlights rising demand for its CPAP and ventilator devices, with shipment volumes up more than 12% year-over-year in Q1. The company reports growth in its Asia-Pacific and EMEA regions, now representing 45% of total revenues. Liquidity remains strong, with cash and marketable securities totaling approximately US$2.3 billion as of Q1 end. Investors should weigh these operational strengths against potential headwinds such as slowing hospital equipment orders in key European markets and currency fluctuations that could trim reported sales growth by 100 to 150 basis points in the second half of fiscal 2026.